MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-06-0012078
Augxen Pharma Private Limited - pharma in Bharuch, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.52 Cr
▲ 134% YoY
Net profit · FY 2025
₹7.14 Lakh
Net margin 0.3%
EBITDA · FY 2025
₹2.12 Cr
EBITDA margin 7.7%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹2.5 Cr
Issued & subscribed
Open charges
₹10.48 Cr
Satisfied ₹8.35 Cr
Company age
5 yrs
Est. 2021
Employees · EPFO
32
Provident fund records
About Augxen Pharma Private Limited
Data last updated:
Augxen Pharma Private Limited is a private limited company based in Bharuch, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33110GJ2021PTC124296. Its GSTIN is 24AAVCA5303J1ZK (Gujarat).
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.5 Cr. It is led by directors including Vandanaben Maheshbhai Matholiya and Gajera Manishaben Vijaybhai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ef A 801 Sidhdhi Heights Opp Swaminaraya Temple Zadeshwar, Bharuch, Gujarat, India – 392011.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.52 Cr, a growth of 134% compared to the previous year. For the same year it recorded a net profit of ₹7.14 Lakh (net margin 0.3%) and EBITDA of ₹2.12 Cr (EBITDA margin 7.7%).
The company has about 32 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10.48 Cr and satisfied charges of ₹8.35 Cr on record.
Augxen Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0012078). For more details, the company can be reached via its website augxen.com.
Company details
CIN U33110GJ2021PTC124296
Registration Number 124296
Incorporation Date 22 July 2021
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-GJ-06-0012078
Key People
Vandanaben Maheshbhai Matholiya Director Gajera Manishaben Vijaybhai Director Ranjanaben Patil Director Recognitions & Rankings of Augxen Pharma
Contact details
Augxen Pharma Private Limited's registered office is in Bharuch, Gujarat. Its website is augxen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressEf A 801 Sidhdhi Heights Opp Swaminaraya Temple Zadeshwar, Bharuch, Gujarat, India – 392011
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Augxen Pharma Private Limited, buy the company report.
Comprehensive company report
Augxen Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Augxen Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Augxen Pharma Private Limited, buy the company report.
Financials of Augxen Pharma Private Limited
FY 2025 filings availableAugxen Pharma Private Limited reported revenue of ₹27.52 Cr (up 134% YoY) for FY 2025.
Revenue · FY 2025
₹27.52 Cr ▲ 134%
Net profit · FY 2025
₹7.14 Lakh margin 0.3%
EBITDA · FY 2025
₹2.12 Cr margin 7.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 134%
EBITDA CAGR growth
1 year
▲ 151%
3 years · compounded
▲ 252%
Revenue rose 134% in the latest year. EBITDA rose 151% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.12 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹7.14 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 7.7% | |||
| Net Profit Margin | 0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Augxen Pharma Private Limited, buy the company report.
Board of directors of Augxen Pharma Private Limited
Augxen Pharma has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vandanaben Maheshbhai Matholiya | Director | 22 Jul 2021 | 5 Years 3 Months | Current |
| Gajera Manishaben Vijaybhai | Director | 22 Jul 2021 | 5 Years 3 Months | Current |
| Ranjanaben Patil | Director | 22 Jul 2021 | 5 Years 3 Months | Current |
| Savanbhai Devchandbhai Tibadiya | Director | 22 Jul 2021 | 5 Years 3 Months | Current |
| Hardik Bhadabhai Soliya | Director | 22 Jul 2021 | 5 Years 3 Months | Current |
Peer comparison
Augxen Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sain Medicaments Private Limited | ₹27.64 Cr (FY 2025) | 4.0% | Telangana, India | |||
| Jips Pharmaceuticals Private Limited | ₹27.63 Cr (FY 2023) | 19.0% | Chandigarh, India | |||
| Quixotic Pharma Private Limited | ₹27.58 Cr (FY 2025) | -8.0% | Punjab, India | |||
| Augxen Pharma Private Limitedthis company | ₹27.52 Cr (FY 2025) | ₹7.14 Lakh | 0.3% | 134.0% | 32 | Bharuch, Gujarat, India |
| Cirex Pharmaceuticals Private Limited | ₹27.51 Cr (FY 2025) | 487.0% | Hyderabad, Telangana, India | |||
| Acme Diet Care Private Limited | ₹27.35 Cr (FY 2025) | 17.0% | Ahmedabad, Gujarat, India | |||
| Riconpharma India Private Limited | ₹27.3 Cr (FY 2024) | 24.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Augxen Pharma Private Limited, buy the company report.
Auditor
Augxen Pharma Private Limited is audited by Kanudawala & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kanudawala & Associates | FY 2022 | 135176W |
Shareholding
The shareholding of Augxen Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Augxen Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10.48 Cr
Satisfied charges
₹8.35 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jan 2026 | 101228690 | Others | ₹41.97 Lakh | Open | |
| 03 Oct 2024 | 101035869 | Axis Bank Limited | ₹9.93 Cr | Open | |
| 03 Nov 2022 | 100662508 | Hdfc Bank Limited | ₹12.94 Lakh | Open | |
| 09 May 2022 | 100575911 | Hdfc Bank Limited | ₹8.35 Cr | Satisfied |
To see the full charge records of Augxen Pharma Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Augxen Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Augxen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Augxen Pharma Private Limited has a workforce of 32 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.
Employee count
32
Active EPFO establishments
1
Employee growth
18.5%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 32 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Augxen Pharma Private Limited, buy the company report.
GST
Augxen Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAVCA5303J1ZK | Gujarat | Active | 30 Jul 2021 |
To see the full GST registrations and return filing status of Augxen Pharma Private Limited, buy the company report.
Recent activity
Augxen Pharma Private Limited has 6 board changes on record since 2021: 5 appointments and 1 cessation. The latest: Vaishali Bhargav Kakaniya ceased to be Director on 06 Dec 2021.
Charges
A charge with Others amounted to Rs. 0.42 Cr with Charge ID 101228690 was registered on 28 Jan 2026.
AGM
Augxen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Augxen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge registered on 09 May 2022 via Charge ID 100575911 with Hdfc Bank Limited was fully satisfied on 22 Nov 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 9.93 Cr with Charge ID 101035869 was registered on 03 Oct 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 8.35 Cr registered on 09 May 2022 with Charge ID 100575911 was modified on 16 Apr 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.13 Cr with Charge ID 100662508 was registered on 03 Nov 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.35 Cr with Charge ID 100575911 was registered on 09 May 2022.
Ceased
Vaishali Bhargav Kakaniya ceased to be Director.
Appointed
Gajera Manishaben Vijaybhai was appointed as Director.
Appointed
Hardik Bhadabhai Soliya was appointed as Director.
Appointed
Ranjanaben Patil was appointed as Director.
3 earlier events are in the company report.
Frequently asked questions
Augxen Pharma is an active private limited company based in Bharuch, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 July 2021 (5+ years old) and is registered under CIN U33110GJ2021PTC124296.
Augxen Pharma has 5 current directors:
- Vandanaben Maheshbhai Matholiya - Director
- Gajera Manishaben Vijaybhai - Director
- Ranjanaben Patil - Director
- Savanbhai Devchandbhai Tibadiya - Director
- Hardik Bhadabhai Soliya - Director
The latest financial statements of Augxen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Augxen Pharma is 24AAVCA5303J1ZK, registered in Gujarat.
The CIN (Corporate Identification Number) of Augxen Pharma is U33110GJ2021PTC124296. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Augxen Pharma was incorporated on 22 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Augxen Pharma by revenue are Sain Medicaments Private Limited, Jips Pharmaceuticals Private Limited, Quixotic Pharma Private Limited, Cirex Pharmaceuticals Private Limited, Acme Diet Care Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vaishali Bhargav Kakaniya ceased to be Director on 06 Dec 2021. Gajera Manishaben Vijaybhai was appointed as Director on 22 Jul 2021. Hardik Bhadabhai Soliya was appointed as Director on 22 Jul 2021. Augxen Pharma has 6 board changes on record in total.
Yes, Augxen Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-06-0012078).
Augxen Pharma can be reached through the website augxen.com. Its registered office is in Bharuch, Gujarat, India.
The registered office of Augxen Pharma is at Ef A 801 Sidhdhi Heights Opp Swaminaraya Temple Zadeshwar, Bharuch, Gujarat, India – 392011.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages